Arterial thromboses: An innovative treatment approach
Scientists have shown in an animal model that the CXCL12 messenger could be suitable as a target structure for the treatment of blood-clotting disorders.
Apr 21, 2022
0
2
Scientists have shown in an animal model that the CXCL12 messenger could be suitable as a target structure for the treatment of blood-clotting disorders.
Apr 21, 2022
0
2
Portable MRI machines, an emerging technology that makes medical imaging accessible even in remote locations, detected ischemic strokes, or strokes caused by clotting, in 90% of patients scanned, according to a study led ...
Apr 20, 2022
0
86
Almost two thirds of acute stroke patients fail to survive more than a decade and have high risk of recurrence, prompting researchers to call for better patient care.
Apr 15, 2022
0
35
Researchers have published the results of a clinical trial that led the U.S. Food and Drug Administration to recently approve mitapivat for the treatment of adults with pyruvate kinase deficiency—a rare genetic condition ...
Apr 14, 2022
0
31
A new Blood Advances study suggests that people with cancer and non-O blood types, such as types A, B, and AB, face an increased risk of developing venous thromboembolism (VTE), or blood clots in the veins, three months ...
Apr 13, 2022
0
9
DEAR MAYO CLINIC: I have a relative who was diagnosed with polycythemia vera. What is this disorder, and can it be treated? Is any new research being conducted on polycythemia vera?
Apr 13, 2022
0
12
Around one in 10 Canadians has kidney disease and millions more are at risk. According to the Kidney Foundation of Canada, the number of people living with end-stage kidney disease or kidney failure has grown 35 percent since ...
Apr 13, 2022
0
4
The rare blood clot side-effect associated with some COVID-19 vaccines could be the result of genetics, new research has found, paving the way for a potential genetic screening test.
Apr 11, 2022
0
185
A new web-based application developed by Penn State researchers could help pharmacists and other health care providers improve patient safety by reducing unintended interactions between medical and recreational marijuana ...
Apr 6, 2022
0
1
Patients undergoing noncardiac surgery who received a single dose of tranexamic acid (TXA), which promotes blood clotting, at the beginning and end of their surgery had significantly less serious bleeding and needed fewer ...
Apr 4, 2022
0
2